Leadership Team
Driven by a passion to give patients better access to our groundbreaking technology
Sacha Loiseau, Ph.D
Founder, Chairman of the Board and CEO
SACHA FOUNDED MAUNA KEA TECHNOLOGIES IN 2000
Sacha is the co-inventor of the probe-based Confocal Laser Endomicroscopy technology and conducted the development of the Cellvizio product line, raising over €120m with private and public investors, including €56.5m through an IPO in July 2011 on the NYSE Euronext Paris stock exchange. In 2013, Sacha was named co-lead of France’s Re-industrialization Plan for Medical Devices by the French President and then a member of the Committee for the Future of Medicine. Sacha has served as a mentor of the Polytechnique-Stanford Ignite Program for young MedTech entrepreneurs for several years. Sacha was instrumental in the foundation of the association Medtech in France, of which he is Vice-President.
Sacha started his career at the National Center for Space Studies (CNES) in Toulouse and at the Paris Observatory, then joined NASA’s Jet Propulsion Laboratory (JPL) in Pasadena, California, as a research scientist. Sacha is a graduate of Ecole Polytechnique and holds a Ph.D. in Astrophysics and Optical Instrumentation from University Paris-Diderot. He is the author of multiple scientific papers and holds 7 international patents and was the 2018 recipient of the Marius Lavet Prize.
Nathalie Lecoq
Chief Operating Officer
NATHALIE BRINGS 30 YEARS OF EXPERIENCE IN BUSINESS UNIT MANAGEMENT AND TRANSVERSAL LEADERSHIP ROLES FROM LEADING GLOBAL MEDTECH COMPANIES.
Côme de La Tour du Pin
Chief Financial Officer
CÔME BRINGS SOLID EXPERIENCE IN LISTED COMPANIES AND INVESTOR RELATIONS.
François Lacombe, Ph.D.
Chief Scientific Officer
FRANÇOIS LACOMBE IS A WORLD-RENOWNED SCIENTIST AND THE AUTHOR OF MORE THAN 150 SCIENTIFIC PAPERS AND 10 PATENTS.
Olivier Coeffic
Vice President, R&D
OLIVIER COEFFIC HAS MORE THAN 18 YEARS EXPERIENCE IN THE MEDICAL DEVICE INDUSTRY
Olivier is a passionate R&D leader with over 18 years experience in the medical device industry. Following his initial tenure at GE Healthcare, he spent 12 years at Capsule Technologies, contributing to its growth from a startup to a global leader now under the Philips umbrella. With a proven track record of managing international and multicultural R&D teams based in both France and the United States, Olivier joined Mauna Kea’s R&D leadership in July 2021. He holds a Master’s degree in Engineering from Ecole Centrale Paris.
Daryl Donatelli
Vice President, Global Marketing & U.S. Sales
DARYL DONATELLI IS A MARKETING AND SALES EXECUTIVE WITH OVER 19 YEARS OF EXPERIENCE DRIVING TOP AND BOTTOM-LINE GROWTH OF MEDICAL DEVICE, OTC/CONSUMER HEALTH, AND RX PHARMACEUTICAL PORTFOLIOS.
Bruno Villaret
Vice-President, International Sales
BRUNO VILLARET HAS A RICH INTERNATIONAL BACKGROUND GARNERED FROM HIS STUDIES IN LEBANON, ITALY AND FRANCE WHERE HE BECAME FLUENT IN FOUR LANGUAGES.
Bruno started his career as an Export Area Manager for Sapag, a division of Saint-Gobain, then worked 15 years for Tyco Fire & Building Products where he was appointed General Manager of Asia-Pacific. In January of 2009, Bruno joined Mauna Kea Technologies with a mission to develop the Asia-Pacific market for Cellvizio. Bruno is responsible for sales of Cellvizio products in all territories outside the United-States: EMEA, APAC and LATAM.
News
YOU MIGHT ALSO LIKE TO READ
Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio
Mauna Kea Technologies Announces Endorsement from The American Foregut Society for Payor Policy Coverage of Cellvizio®
Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024
Find out more by downloading the
Cellvizio Brochure